| Document Date: 2013-07-30 07:47:52
Open Document File Size: 70,54 KBShare Result on Facebook
City Gedeon Richter / Senju Pharmaceutical / / Company Vertex US / Kyowa Hakko Kirin / Novartis Pharma / SAMA Pharma / GlaxoSmithKline US / Ube Industries / Handok Pharmaceuticals / SONKEI Pharmaceuticals / / Country Switzerland / Hungary / France / Japan / United States / Korea / United Kingdom / / Event FDA Phase / / MarketIndex TA 1790 / / MedicalCondition Glaucoma / Insomnia / Diabetic nephropathy / Type2 diabetes mellitus / Refractory Kawasaki disease / Pediatric ulcerative colitis / Atopic dermatitis / Secondary hyperparathyroidism / Schizophrenia / Dementia / Hyperphosphatemia / Type2 diabetes / Alzheimer's / dermatitis / urinary incontinence / Erectile dysfunction / Chronic inflammatory demyelinating polyradiculoneuropathy / reflux disease / Hematological cancer / lateral sclerosis / Chronic kidney disease / Behcet's disease / diabetes mellitus / Obesity / Multiple sclerosis / Psoriasis / Pediatric allergic rhinitis / Atrial fibrillation / Pediatric hyperphosphatemia / Depression / Refractory pruritus / Chronic hepatitis C / Acute ischemic stroke / Pediatric Crohn's disease / Asthma / / MedicalTreatment hemodialysis / / Organization US NDA / / Person Category (Indications) Tenelia (Teneligliptin) / / Product Pegasys / Remicade / GB-1057 / OTX015 / MT-4580 / MP-124 / MP-157 / TA-1790 / MT-210 / MCC-847 / Bile acid / TA-7284 / NS3-4A / sTU-199 / MT-1303 / MT-3995 / MT-9938 / MP-424 / Type2 / SGLT2 / Y-803 / TA-7906 / MP-513 / /
SocialTag |
(2) State of New Product Development (As of July 31, 2013) i. Pipeline in Japan New Molecular Entities Development code (Generic name)